PL2540843T3 - Polimorfizmy genetyczne w związanym z wiekiem zwyrodnieniu plamki żółtej - Google Patents
Polimorfizmy genetyczne w związanym z wiekiem zwyrodnieniu plamki żółtejInfo
- Publication number
- PL2540843T3 PL2540843T3 PL12185155T PL12185155T PL2540843T3 PL 2540843 T3 PL2540843 T3 PL 2540843T3 PL 12185155 T PL12185155 T PL 12185155T PL 12185155 T PL12185155 T PL 12185155T PL 2540843 T3 PL2540843 T3 PL 2540843T3
- Authority
- PL
- Poland
- Prior art keywords
- age
- macular degeneration
- related macular
- genetic polymorphisms
- polymorphisms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6846—Common amplification features
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/137—Ligase Chain Reaction [LCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11166708P | 2008-11-05 | 2008-11-05 | |
| US17485609P | 2009-05-01 | 2009-05-01 | |
| EP09748682A EP2356250A2 (en) | 2008-11-05 | 2009-11-05 | Genetic polymorphisms in age-related macular degeneration |
| EP12185155.4A EP2540843B1 (en) | 2008-11-05 | 2009-11-05 | Genetic polymorphisms in age-related macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2540843T3 true PL2540843T3 (pl) | 2014-12-31 |
Family
ID=41650496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12185155T PL2540843T3 (pl) | 2008-11-05 | 2009-11-05 | Polimorfizmy genetyczne w związanym z wiekiem zwyrodnieniu plamki żółtej |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20120003641A1 (pl) |
| EP (2) | EP2540843B1 (pl) |
| JP (1) | JP5701216B2 (pl) |
| KR (1) | KR101719376B1 (pl) |
| CN (2) | CN103333952B (pl) |
| AU (1) | AU2009313475B2 (pl) |
| CA (1) | CA2740242A1 (pl) |
| DK (1) | DK2540843T3 (pl) |
| ES (1) | ES2498274T3 (pl) |
| HK (1) | HK1173751A1 (pl) |
| IL (1) | IL211995A (pl) |
| MX (1) | MX2011004763A (pl) |
| PL (1) | PL2540843T3 (pl) |
| SI (1) | SI2540843T1 (pl) |
| WO (1) | WO2010054110A2 (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
| US10337071B2 (en) | 2008-07-25 | 2019-07-02 | National Cancer Center | Oncogene NRF2 |
| EP2678441B1 (en) * | 2011-02-23 | 2017-10-18 | Sanofi | Single nucleotide polymorphisms in the promoter of vegfa gene and their use as predictive markers for anti-vegf treatments |
| JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
| WO2012159089A1 (en) | 2011-05-19 | 2012-11-22 | Sequenom, Inc. | Products and processes for multiplex nucleic acid identification |
| JP2014527175A (ja) * | 2011-08-26 | 2014-10-09 | エフ．ホフマン−ラ ロシュ アーゲー | 精神発達、神経または神経精神障害の処置における臨床的有用性を予測するための方法 |
| ES2687951T3 (es) * | 2011-10-14 | 2018-10-30 | F. Hoffmann-La Roche Ag | Anticuerpos anti-HtrA1 y procedimientos de uso |
| US20140004105A1 (en) * | 2012-06-29 | 2014-01-02 | Sequenom, Inc. | Age-related macular degeneration diagnostics |
| MX2016001854A (es) | 2013-08-12 | 2016-09-06 | Genentech Inc | Composiciones y metodo para tratar condiciones asociadas con el complemento. |
| TW201623337A (zh) | 2014-05-01 | 2016-07-01 | 建南德克公司 | 抗－因子ｄ抗體變異體及其用途 |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| DK3170005T3 (da) | 2014-07-18 | 2019-07-08 | Sanofi Sa | Fremgangsmåde til forudsigelse af resultatet af en behandling med aflibercept hos en patient, der mistænkes for at lide af cancer |
| EP3233115B1 (en) * | 2014-12-19 | 2021-02-17 | Children's Hospital Medical Center | Methods and compositions related to transplant-associated thrombotic microangiopathy |
| CA2983224A1 (en) | 2015-04-24 | 2016-10-27 | Agena Bioscience, Inc. | Multiplexed method for the identification and quantitation of minor alleles and polymorphisms |
| CN104894261B (zh) * | 2015-06-02 | 2020-02-14 | 北京医院 | 一种预测雷珠单抗治疗年龄相关性黄斑变性疗效的试剂盒 |
| CN104878105B (zh) * | 2015-06-02 | 2017-10-31 | 北京医院 | 一种预测雷珠单抗治疗年龄相关性黄斑变性疗效的试剂 |
| JP2018536650A (ja) | 2015-10-30 | 2018-12-13 | ジェネンテック， インコーポレイテッド | 抗ｄ因子抗体変異体コンジュゲート及びその使用 |
| US10407510B2 (en) | 2015-10-30 | 2019-09-10 | Genentech, Inc. | Anti-factor D antibodies and conjugates |
| SG11201805420SA (en) | 2015-12-30 | 2018-07-30 | Kodiak Sciences Inc | Antibodies and conjugates thereof |
| WO2017148904A1 (en) * | 2016-02-29 | 2017-09-08 | Franz Grus | Predictive markers useful in the treatment of wet age-related macular degeneration |
| EP3472151A4 (en) | 2016-06-21 | 2020-03-04 | Orion Ophthalmology LLC | CARBOCYCLIC PROLINAMIDE DERIVATIVES |
| KR102595723B1 (ko) | 2016-06-21 | 2023-10-27 | 오리온 옵탈몰로지 엘엘씨 | 헤테로시클릭 프롤린아미드 유도체 |
| CN114786731A (zh) | 2019-10-10 | 2022-07-22 | 科达制药股份有限公司 | 治疗眼部病症的方法 |
| CN113373236B (zh) * | 2021-02-19 | 2021-12-31 | 中国科学院北京基因组研究所(国家生物信息中心) | 一种获得中国人群个体年龄的方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8311018D0 (en) | 1983-04-22 | 1983-05-25 | Amersham Int Plc | Detecting mutations in dna |
| US4998617A (en) | 1986-09-15 | 1991-03-12 | Laura Lupton Inc | Facial cosmetic liquid make up kit |
| US6270961B1 (en) | 1987-04-01 | 2001-08-07 | Hyseq, Inc. | Methods and apparatus for DNA sequencing and DNA identification |
| US5202231A (en) | 1987-04-01 | 1993-04-13 | Drmanac Radoje T | Method of sequencing of genomes by hybridization of oligonucleotide probes |
| US5176996A (en) | 1988-12-20 | 1993-01-05 | Baylor College Of Medicine | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| US5256775A (en) | 1989-06-05 | 1993-10-26 | Gilead Sciences, Inc. | Exonuclease-resistant oligonucleotides |
| FR2650840B1 (fr) | 1989-08-11 | 1991-11-29 | Bertin & Cie | Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications |
| US5264564A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences | Oligonucleotide analogs with novel linkages |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
| US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| US5952172A (en) | 1993-12-10 | 1999-09-14 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| US5968740A (en) | 1995-07-24 | 1999-10-19 | Affymetrix, Inc. | Method of Identifying a Base in a Nucleic Acid |
| SI1325932T1 (pl) | 1997-04-07 | 2005-08-31 | Genentech Inc | |
| US6455249B1 (en) | 1997-09-10 | 2002-09-24 | National Institutes Of Health | Method of amplifying DNA and RNA mismatch cleavage products |
| CN102618644A (zh) * | 2004-11-18 | 2012-08-01 | 耶鲁大学 | 治疗眼病的方法和组合物 |
| WO2008103299A2 (en) * | 2007-02-16 | 2008-08-28 | Massachusetts Eye & Ear Infirmary | Methods and compositions for prognosing, detecting, and treating age-related macular degeneration |
-
2009
- 2009-11-05 EP EP12185155.4A patent/EP2540843B1/en active Active
- 2009-11-05 JP JP2011534924A patent/JP5701216B2/ja active Active
- 2009-11-05 CN CN201310181349.5A patent/CN103333952B/zh active Active
- 2009-11-05 ES ES12185155.4T patent/ES2498274T3/es active Active
- 2009-11-05 CA CA2740242A patent/CA2740242A1/en not_active Abandoned
- 2009-11-05 MX MX2011004763A patent/MX2011004763A/es active IP Right Grant
- 2009-11-05 KR KR1020117010284A patent/KR101719376B1/ko active IP Right Grant
- 2009-11-05 CN CN200980144066.5A patent/CN102203296B/zh active Active
- 2009-11-05 DK DK12185155.4T patent/DK2540843T3/da active
- 2009-11-05 EP EP09748682A patent/EP2356250A2/en not_active Withdrawn
- 2009-11-05 SI SI200931009T patent/SI2540843T1/sl unknown
- 2009-11-05 AU AU2009313475A patent/AU2009313475B2/en active Active
- 2009-11-05 WO PCT/US2009/063434 patent/WO2010054110A2/en active Application Filing
- 2009-11-05 PL PL12185155T patent/PL2540843T3/pl unknown
- 2009-11-05 US US13/127,433 patent/US20120003641A1/en not_active Abandoned
-
2011
- 2011-03-29 IL IL211995A patent/IL211995A/en active IP Right Grant
-
2012
- 2012-02-16 HK HK13100664.0A patent/HK1173751A1/xx unknown
-
2016
- 2016-07-20 US US15/215,426 patent/US20170159114A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN102203296A (zh) | 2011-09-28 |
| EP2356250A2 (en) | 2011-08-17 |
| DK2540843T3 (da) | 2014-09-01 |
| BRPI0914368A2 (pt) | 2015-10-20 |
| MX2011004763A (es) | 2011-06-01 |
| HK1173751A1 (en) | 2013-05-24 |
| KR101719376B1 (ko) | 2017-03-23 |
| WO2010054110A2 (en) | 2010-05-14 |
| EP2540843A2 (en) | 2013-01-02 |
| AU2009313475B2 (en) | 2016-06-02 |
| EP2540843B1 (en) | 2014-07-02 |
| CA2740242A1 (en) | 2010-05-14 |
| KR20110081836A (ko) | 2011-07-14 |
| EP2540843A3 (en) | 2013-05-29 |
| ES2498274T3 (es) | 2014-09-24 |
| CN102203296B (zh) | 2014-12-03 |
| CN103333952B (zh) | 2015-07-29 |
| JP5701216B2 (ja) | 2015-04-15 |
| CN103333952A (zh) | 2013-10-02 |
| SI2540843T1 (sl) | 2014-10-30 |
| JP2012507988A (ja) | 2012-04-05 |
| IL211995A (en) | 2014-04-30 |
| AU2009313475A1 (en) | 2010-05-14 |
| WO2010054110A3 (en) | 2010-08-19 |
| IL211995A0 (en) | 2011-06-30 |
| US20170159114A1 (en) | 2017-06-08 |
| US20120003641A1 (en) | 2012-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1173751A1 (en) | Genetic polymorphisms in age-related macular degeneration | |
| IL247144A (en) | Multiple genetic occurrences of age-dependent staining | |
| PL2145914T3 (pl) | Preparaty plastyfikatorów | |
| EP2227780A4 (en) | GENETIC ANALYSIS | |
| ZA200908481B (en) | Compositions and methods for altering gene expression | |
| IL193396A0 (en) | Variants in complement regulatory genes predict age-related macular degeneration | |
| PL2187880T3 (pl) | Kompozycje i sposoby do leczenia zwyrodnienia plamki żółtej | |
| ZA201100093B (en) | Novel genes involved in biosynthesis | |
| GB0800702D0 (en) | Genes | |
| PL2100661T3 (pl) | Kompleksowe kompozycje cyklopropenu | |
| EP2292798A4 (en) | HYBRIDIZATION IN SITU D ARN | |
| GB2466379B (en) | Protein stabilizer | |
| IL190795A0 (en) | Genes associated with macular degeneration | |
| EP2283163A4 (en) | POLYMORPHISMS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION AND METHODS OF ASSESSING RISK FOR A PATIENT | |
| EP2249871A4 (en) | OPHTHALMIC COMPOSITION | |
| GB0816702D0 (en) | Complement proteins | |
| EP2276501A4 (en) | METHODS AND COMPOSITIONS AGAINST GENETIC AND NETWORK DISEASES | |
| EP2421880A4 (en) | COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY | |
| TWI350891B (en) | Omnibus quasi-hydrosystem | |
| GB0704573D0 (en) | Multi-use retaining means | |
| GB0811149D0 (en) | Gene | |
| HU3547U (en) | Horizontal axle grinder | |
| EP2280612A4 (en) | METHOD FOR MAINTAINING INTESTINAL BACTERIA IN BALANCE | |
| GB0806583D0 (en) | Edging member | |
| GB0820026D0 (en) | Improvements in pinch-bolt type connections |